Angiogenesis, thrombospondin-1 and cervical carcinogenesis

Ming Ping Wu, Cheng-Yang Chou

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Angiogenesis, the growth of new vessels from existing vasculature, plays an essential role in tumor development. The process involves interaction among cancer cells, endothelial cells, and components of the extracellular matrix, and is regulated by the balance of angiogenesis activators and angiogenesis inhibitors. This review profiles some fundamental concepts of angiogenesis, the importance of angiogenesis in cervical neoplasm, and the role of thrombospondin-1 as an angiogenesis inhibitor in cervical carcinogenesis. The usefulness and limitations of microvessel density in evaluation of angiogenic status are also discussed. Recent research and evolving concepts have led to a paradigm shift in anticancer therapy, from conventional cancer-centered chemotherapy to angiogenic or "metronomic" chemotherapy and/or combined angiogenesis inhibitors. The epigenetic strategy, which views the tumor system as a whole, transcends the cancer gene-centered approach.

Original languageEnglish
Pages (from-to)128-138
Number of pages11
JournalTaiwanese Journal of Obstetrics and Gynecology
Volume44
Issue number2
DOIs
Publication statusPublished - 2005 Jan 1

Fingerprint

Thrombospondin 1
Angiogenesis Inhibitors
Carcinogenesis
Neoplasms
Drug Therapy
Neoplasm Genes
Cellular Structures
Microvessels
Epigenomics
Uterine Cervical Neoplasms
Extracellular Matrix
Endothelial Cells
Growth
Research

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynaecology

Cite this

@article{c835423f7ae64ee28ff005246b232053,
title = "Angiogenesis, thrombospondin-1 and cervical carcinogenesis",
abstract = "Angiogenesis, the growth of new vessels from existing vasculature, plays an essential role in tumor development. The process involves interaction among cancer cells, endothelial cells, and components of the extracellular matrix, and is regulated by the balance of angiogenesis activators and angiogenesis inhibitors. This review profiles some fundamental concepts of angiogenesis, the importance of angiogenesis in cervical neoplasm, and the role of thrombospondin-1 as an angiogenesis inhibitor in cervical carcinogenesis. The usefulness and limitations of microvessel density in evaluation of angiogenic status are also discussed. Recent research and evolving concepts have led to a paradigm shift in anticancer therapy, from conventional cancer-centered chemotherapy to angiogenic or {"}metronomic{"} chemotherapy and/or combined angiogenesis inhibitors. The epigenetic strategy, which views the tumor system as a whole, transcends the cancer gene-centered approach.",
author = "Wu, {Ming Ping} and Cheng-Yang Chou",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/S1028-4559(09)60124-8",
language = "English",
volume = "44",
pages = "128--138",
journal = "Taiwanese Journal of Obstetrics and Gynecology",
issn = "1028-4559",
publisher = "Elsevier Taiwan LLC",
number = "2",

}

Angiogenesis, thrombospondin-1 and cervical carcinogenesis. / Wu, Ming Ping; Chou, Cheng-Yang.

In: Taiwanese Journal of Obstetrics and Gynecology, Vol. 44, No. 2, 01.01.2005, p. 128-138.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Angiogenesis, thrombospondin-1 and cervical carcinogenesis

AU - Wu, Ming Ping

AU - Chou, Cheng-Yang

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Angiogenesis, the growth of new vessels from existing vasculature, plays an essential role in tumor development. The process involves interaction among cancer cells, endothelial cells, and components of the extracellular matrix, and is regulated by the balance of angiogenesis activators and angiogenesis inhibitors. This review profiles some fundamental concepts of angiogenesis, the importance of angiogenesis in cervical neoplasm, and the role of thrombospondin-1 as an angiogenesis inhibitor in cervical carcinogenesis. The usefulness and limitations of microvessel density in evaluation of angiogenic status are also discussed. Recent research and evolving concepts have led to a paradigm shift in anticancer therapy, from conventional cancer-centered chemotherapy to angiogenic or "metronomic" chemotherapy and/or combined angiogenesis inhibitors. The epigenetic strategy, which views the tumor system as a whole, transcends the cancer gene-centered approach.

AB - Angiogenesis, the growth of new vessels from existing vasculature, plays an essential role in tumor development. The process involves interaction among cancer cells, endothelial cells, and components of the extracellular matrix, and is regulated by the balance of angiogenesis activators and angiogenesis inhibitors. This review profiles some fundamental concepts of angiogenesis, the importance of angiogenesis in cervical neoplasm, and the role of thrombospondin-1 as an angiogenesis inhibitor in cervical carcinogenesis. The usefulness and limitations of microvessel density in evaluation of angiogenic status are also discussed. Recent research and evolving concepts have led to a paradigm shift in anticancer therapy, from conventional cancer-centered chemotherapy to angiogenic or "metronomic" chemotherapy and/or combined angiogenesis inhibitors. The epigenetic strategy, which views the tumor system as a whole, transcends the cancer gene-centered approach.

UR - http://www.scopus.com/inward/record.url?scp=22144455375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22144455375&partnerID=8YFLogxK

U2 - 10.1016/S1028-4559(09)60124-8

DO - 10.1016/S1028-4559(09)60124-8

M3 - Review article

VL - 44

SP - 128

EP - 138

JO - Taiwanese Journal of Obstetrics and Gynecology

JF - Taiwanese Journal of Obstetrics and Gynecology

SN - 1028-4559

IS - 2

ER -